News | February 24, 2026
biomodal expands multiomic reach with Element Biosciences pact
The collaboration merges biomodal’s 5-base and 6-base sequencing solutions, duet +modC and duet evoC
The collaboration merges biomodal’s 5-base and 6-base sequencing solutions, duet +modC and duet evoC
Dr. Grant brings to the table significant BOD governance, global business development, and corporate development expertise
Her previous role at Novartis, where she was general manager, data & digital, in global drug development, also included accountability for driving the DCT strategy, programs and platforms
Although PCM has advanced substantially in recent years, most of the valuable technical information resides with private companies and academic publications across multiple platforms
Subscribe To Our Newsletter & Stay Updated
